(Q35198453)

7 August 2017

1 reference

title

Progress in lung cancer chemoprevention (English)

1 reference

7 August 2017

Victor Cohen

1

1 reference

PubMed ID

12915810

7 August 2017

Fadlo R Khuri

series ordinal

2

1 reference

7 August 2017

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

10

1 reference

7 August 2017

4

1 reference

7 August 2017

315-324

1 reference

7 August 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Cigarette smoking and lung cancer in New Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Lung cancer incidence rate for male ex-smokers according to age at cessation of smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Lung carcinoma in former smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Recent advances in chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Biomarkers as intermediate end points in chemoprevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Criteria for the validation of surrogate endpoints in randomized experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Retinoids in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

beta-Carotene: an unusual type of lipid antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

CHEMOPREVENTION OF LUNG CANCER: The Rise and Demise of Beta-Carotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Lycopene: a biologically important carotenoid for humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

The selective cytotoxic effect of carotenoids and alpha-tocopherol on human cancer cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Serum selenium and subsequent risk of cancer among Finnish men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

Patterns of Absolute Risk of Lung Cancer Mortality in Former Smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000406

10.1177/107327480301000406

21 January 2018

Identifiers

DOI

0 references

PubMed ID

12915810

1 reference

PubMed ID

12915810